Quick Answer
Magnesium Migraine Meta-Analysis has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: OBJECTIVE: To systematically review and synthesize current evidence on sex-related clinical differences in migraine, including treatment outcomes and reproductive management, and to provide evidence-based or expert consensus recommendations where high-quality data are lacking.
Key Takeaways
- 01OBJECTIVE: To systematically review and synthesize current evidence on sex-related clinical differences in migraine, including treatment outcomes and reproductive management, and to provide evidence-based or expert consensus recommendations where high-quality data are lacking. [Braca S (2026)]
- 02To address anticipated evidence gaps, a structured Delphi consensus process complemented the review. [Braca S (2026)]
- 03CONCLUSIONS: Evidence is limited, but sex (likely mediated by sex hormones) influence the clinical course of migraine, and likely treatment response. [Braca S (2026)]
- 04Although sex differences are recognized in migraine, robust sex-specific guidance for management remains limited. [Braca S (2026)]
The current Migaku evidence database contains 2 reusable source documents for Magnesium Migraine Meta-Analysis. This answer focuses on strength of evidence and what the studies can or cannot prove.
- OBJECTIVE: To systematically review and synthesize current evidence on sex-related clinical differences in migraine, including treatment outcomes and reproductive management, and to provide evidence-based or expert consensus recommendations where high-quality data are lacking. [Braca S (2026); evidence level 1]
- To address anticipated evidence gaps, a structured Delphi consensus process complemented the review. [Braca S (2026); evidence level 1]
- CONCLUSIONS: Evidence is limited, but sex (likely mediated by sex hormones) influence the clinical course of migraine, and likely treatment response. [Braca S (2026); evidence level 1]
- Although sex differences are recognized in migraine, robust sex-specific guidance for management remains limited. [Braca S (2026); evidence level 1]
- Associated symptoms may include nausea, vomiting, photophobia, and phonophobia []. [Rodriguez Juan Pablo (2025); evidence level 3]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources